United States - English - NLM (National Library of Medicine)

karatica co., ltd - hyaluronate sodium (unii: yse9ppt4th) (hyaluronic acid - unii:s270n0trqy) - hyaluronate sodium 99.97 g in 100 g - multi function - anti-wrinkle moisturizing 1) apply toner or emulsion to cleansed face. 2) open the pouch and take the patches out from the plastic case carefully. (be careful not to touch the center area with fingers.) 3) remove the white films on the patches and attach it on the desired area. 4) remove the transparent films and press vertically the patches on the skin several times with your fingers. 5) remove the patches after 2 hours (or next morning) and clean the face. *2 or 3 day interval or 2 times per week is recommended for regular use.

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - hyaluronate sodium (unii: yse9ppt4th) (hyaluronate sodium - unii:yse9ppt4th) -

United States - English - NLM (National Library of Medicine)

pharmaceutica north america, inc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 30 mg in 1 g - diclofenac sodium gel is indicated for the topical treatment of actinic keratoses (ak). sun avoidance is indicated during therapy. diclofenac sodium gel is contraindicated in patients with a known hypersensitivity to diclofenac, benzyl alcohol, polyethylene glycol monomethyl ether 350 and/or hyaluronate sodium.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - sodium hyaluronate - unknown - sodium hyaluronate ungrouped active 0.0 - active constituent

New Zealand - English - Ministry for Primary Industries

dechra veterinary products nz limited - sodium hyaluronate - sodium hyaluronate 17 g/litre - musculoskeletal modifier

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - 44757 - synovial fluid supplementation substance - a very highly purified viscoelastic, sterile solution of highly purified, high molecular weight (2.4-3.6 million daltons) hyaluronan (also known as sodium hyaluronate) in phosphate-buffered saline; extracted from bacterial cells. a polysaccharide consisting of a repeating disaccharide of n-acetylglucosamine and sodium glucuronate, linked by alternating b? 1,3 and b? 1,4 glycosidic bonds. euflexxa is indicated for the treatment of pain caused by osteoarthritis of the knee joint or other synovial joints. euflexxa aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Australia - English - Department of Health (Therapeutic Goods Administration)

surgical specialties pty ltd - 44757 - synovial fluid supplementation substance - monovisc? cross-linked sodium hyaluronate injection is a single, intra-articular injection of cross-linked sodium hyaluronate designed to treat the symptoms of osteoarthritis. the actions of monovisc? are lubrication and mechanical support. monovisc is indicated as a viscoelastic supplement or a replacement for synovial fluid in human knee joints. monovisc is well suited for treatment of the symptoms of mild to moderate osteoarthritis of the human knee joints for patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kela pharma sa-nv - sodium hyaluronate 20 mg/2 ml - solution for injection - 20 mg/2 ml - sodium hyaluronate 20 mg - hyaluronic acid

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dechra regulatory b.v. - sodium hyaluronate 17 mg/ml - solution for injection - 17 mg/ml - sodium hyaluronate 17 mg/ml - hyaluronic acid - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boehringer ingelheim animal health belgium sa-nv - sodium hyaluronate 10 mg/ml - solution for injection - 10 mg/ml - sodium hyaluronate 10 mg/ml - hyaluronic acid - horse